Decision: Favourable

Study Title:

A Multicenter, Randomized, Double-Blind, Parallel-Group Study to Assess the Efficacy and Safety of Oral Etrasimod as Induction and Maintenance Therapy for Moderately to Severely Active Crohn’s Disease

  • NREC Code:

    21-NREC-CT-131

  • Decision:

    Favourable

  • Meeting Date:

    03/11/2021

  • Study Type:

    CT application

  • Principal Investigator:

    Professor Gerard Clarke

  • PI Institution:

    Portiuncula University Hospital

  • Sponsor:

    Alexander Silve

Scroll to Top
Skip to content